This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Veracyte Sd, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jonathan Lehrer and His Work in Prostate Cancer Research.
Introduction
Jonathan Lehrer is an inventor associated with Vancouver, Canada. His patent work concerns the use of immune cell-specific gene expression to support prostate cancer prognosis and predict responsiveness to radiation therapy.
Latest Patents
Lehrer is named on 1 patent: “Use of Immune Cell-Specific Gene Expression for Prognosis of Prostate Cancer and Prediction of Responsiveness to Radiation Therapy.” The patent describes methods, systems, and kits for diagnosing prostate cancer, assessing its prognosis and progression, and identifying patients who may respond to radiation therapy.
Career Highlights
Lehrer is associated with Veracyte SD, Inc. His patent focuses on applying immune cell-specific gene expression to inform clinical assessment and treatment decisions for prostate cancer.
Collaborations
The provided information lists Felix Y. Feng and Elai Davicioni as some of Lehrer’s coworkers.
Conclusion
Jonathan Lehrer’s patent work centers on using gene-expression insights to improve prostate cancer prognosis and help identify patients who may benefit from radiation therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile